This article provides an overview of the prescription medication dutasteride, a 5-alpha reductase inhibitor used to treat enlargement of the prostate gland in men. It outlines the availability, type ...
Dutasteride, on the other hand, received its FDA approval as a treatment for BPH in 2001, under the brand name Avodart.
GlaxoSmithKline has launched its new treatment for moderate-to-severebenign prostatic hyperplasia, Avodart (dutasteride), in the UK. Launch of the drug in the USA, its first market, took place at the ...